INHBE and neoplasm: Inhibins do not have an identified intracellular downstream signaling pathway but bring about their effector functions by inhibiting ligand: receptor interaction of the soluble paracrine factors activin and TGFβ, abundant in both the primary tumour and bone microenvironment [8].